NCT02447666 2019-07-11Study With Azacitidine in Pediatric Subjects With Newly Diagnosed Advanced Myelodysplastic Syndrome (MDS) and Juvenile Myelomonocytic Leukemia (JMML)CelgenePhase 2 Completed28 enrolled 1 FDA